BioNTech’s Bold Bet: Navigating Losses Today for Tomorrow’s Breakthroughs
BioNTech announced a decrease in fourth-quarter 2024 earnings, with profits dropping to €1.08 per share, yet surpassing market expectations. Revenues fell to €1.19 billion, still outperforming analyst predictions. The company…